Get started
INTUITIVE SURGICALINTUITIVE SURGICALINTUITIVE SURGICAL

INTUITIVE SURGICAL

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

1ISRG trade ideas

Intuitive Surgical trade setup. Entry level $ 592 = Target price $643 = Stop loss $578 technically and fundamental bullish with great momentum in the stock, RSI has plenty of upside. Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
NASDAQ:ISRGLong
by Bullishcharts
Buy $ISRG - 1D TFI am long in $ISRG and have opened buy position. 1D MA50 has crossed MA200 and I am expecting the range to be broken to the upside. 1D DC20 has been broken on 18th October. With checking the weekly outlook after a year of ranging this may now be the time for the uptrend to continue. SL can be triggered if daily candle closes below MA50, MA200 and DC20. I have no defined TP at this stage - either going for trailing stop or monitoring indicators (e.g. heavily oversold RSI condition, Stoch RSI and locking profits accordingly if the market goes in favor. Any comments are more than welcomed! Thank you and please trade carefully and with money you can afford to lose. To prove real trade stats please do not hesitate to check eToro - www.etoro.com
NASDAQ:ISRGLong
by drgorogbalazs
$ISRG Impressive earnings For Intuitive Surgical.Looking for a possible long on a good break above $550. Shares of Intuitive Surgical (ISRG) jumped 3.9%, near 550, in after-hours trading on the stock market today. During the third quarter ended Sept. 30, Intuitive Surgical earned $3.43 per share, on an adjusted basis. Earnings increased more than 21% year over year and topped the average estimate of analysts polled by Zacks Investment Research for $2.96 a share. Revenue grew 23% to $1.13 billion and beat analyst forecasts for $1.06 billion. Procedures using Intuitive Surgical's biggest robotic surgery system, da Vinci, ramped up 20% year over year. Evercore ISI analyst Vijay Kumar called the number "impressive." Source Investor bus Daily. Company profile Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
NASDAQ:ISRGLong
by RedHotStocks
Intuitive Surgical heading to ATH.ISRG surgical system enables minimally-invasive surgery, and decreases costs greatly in a industry where Surgical staffing issues are a problem throughout the world. The growth potential for ISRG expands as technology develops for remote medical treatments. There will come the day when many operations will be performed by AI powered robotics. Analysts average price target $583 | Overweight P/e ratio 55 Company profile Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
NASDAQ:ISRGLong
by Bullishcharts
ISRG Short/ Put SpreadISRG Put Spread EXP October 18th. 505/465 Put Spread $13.93 Max Loss 40 point spread Target is $1300 Profit Max loss is $750 Market is trending lower, RSI is showing divergence and this is market wide ISRG is showing a rounding topping pattern which may move toward further support at 460 which will be my exit. Exit 1 = $460 underlying price while trying to get as close as possible to $1300 with a 10% tolerance plus or minus. Exit 2 = Market reversed and I take a $750 loss. It's possible my time target could be too far out and I may hit my target early if the market sells off leading into September.
NASDAQ:ISRGShort
by Synaptic724
INTUITIVE SURGICAL (ISRG)Health Care/ Health Care Equipment Company announced 2Q earnings last week which exceeded expectations -it managed to increase gross margin by eliminating distributors and sell more directly. In 2019 Expected revenue +16.5%, EPS + 14.3%, EBITDA margin +3.4 p.p. (38.5%) In 2020 Expected revenue +23.1%, EPS + 13.7%, EBITDA margin -0.5 p.p. (38.0%) 12M Tgt Px is USD 571.88 (Bloomberg). Since last Friday analyst increased Target Px above USD 600 Company doesn't pay dividend. We are looking to enter long position at current levels - 2.0% portfolio exposure.
NASDAQ:ISRG
by market-shepherd